Novel motif:56: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:48, 9 September 2013
name: | motif56_GANCGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0040040 | thermosensory behavior | 8.459398e-18 |
GO:0009992 | cellular water homeostasis | 4.200364e-11 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.765122e-11 |
GO:0015696 | ammonium transport | 1.967270e-10 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.753194e-9 |
GO:0006396 | RNA processing | 7.770874e-9 |
GO:0019087 | transformation of host cell by virus | 1.526192e-8 |
GO:0043503 | skeletal muscle fiber adaptation | 1.567609e-8 |
GO:0045008 | depyrimidination | 2.047063e-8 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 3.570864e-8 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.745199e-8 |
GO:0016072 | rRNA metabolic process | 4.340556e-8 |
GO:0006244 | pyrimidine nucleotide catabolic process | 4.768567e-8 |
GO:0001510 | RNA methylation | 4.952436e-8 |
GO:0006364 | rRNA processing | 6.471669e-8 |
GO:0034470 | ncRNA processing | 6.846110e-8 |
GO:0071474 | cellular hyperosmotic response | 8.994521e-8 |
GO:0061032 | visceral serous pericardium development | 9.647180e-8 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 9.647180e-8 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 1.301314e-7 |
GO:0051452 | intracellular pH reduction | 1.449517e-7 |
GO:0034505 | tooth mineralization | 1.570201e-7 |
GO:0016090 | prenol metabolic process | 2.810502e-7 |
GO:0016032 | viral reproduction | 4.400649e-7 |
GO:0034660 | ncRNA metabolic process | 4.413896e-7 |
GO:0033169 | histone H3-K9 demethylation | 7.096038e-7 |
GO:0060923 | cardiac muscle cell fate commitment | 7.883383e-7 |
GO:0009451 | RNA modification | 8.219516e-7 |
GO:0045851 | pH reduction | 1.190142e-6 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1.752521e-6 |
GO:0060346 | bone trabecula formation | 2.614330e-6 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 4.861869e-6 |
GO:0042727 | flavin-containing compound biosynthetic process | 4.982635e-6 |
GO:0002536 | respiratory burst involved in inflammatory response | 5.258067e-6 |
GO:0051549 | positive regulation of keratinocyte migration | 5.486153e-6 |
GO:0051645 | Golgi localization | 5.757535e-6 |
GO:0001957 | intramembranous ossification | 6.061089e-6 |
GO:0006491 | N-glycan processing | 6.244802e-6 |
GO:0042423 | catecholamine biosynthetic process | 8.159477e-6 |
GO:0000185 | activation of MAPKKK activity | 8.424684e-6 |
GO:0016577 | histone demethylation | 9.035695e-6 |
GO:0042558 | pteridine-containing compound metabolic process | 9.581813e-6 |
GO:0042416 | dopamine biosynthetic process | 1.076992e-5 |
GO:0051725 | protein de-ADP-ribosylation | 1.187972e-5 |
GO:0042254 | ribosome biogenesis | 1.191914e-5 |
GO:0072166 | posterior mesonephric tubule development | 1.253621e-5 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.345029e-5 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.360302e-5 |
GO:0006882 | cellular zinc ion homeostasis | 1.690297e-5 |
GO:0002635 | negative regulation of germinal center formation | 1.807814e-5 |
GO:0071318 | cellular response to ATP | 1.986301e-5 |
GO:0008078 | mesodermal cell migration | 1.986301e-5 |
GO:0006285 | base-excision repair, AP site formation | 2.139062e-5 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 2.156522e-5 |
GO:0046856 | phosphatidylinositol dephosphorylation | 2.258110e-5 |
GO:0006352 | transcription initiation, DNA-dependent | 2.638207e-5 |
GO:0042851 | L-alanine metabolic process | 2.840920e-5 |
GO:0006482 | protein demethylation | 3.204721e-5 |
GO:0051453 | regulation of intracellular pH | 3.260290e-5 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 3.580995e-5 |
GO:0070534 | protein K63-linked ubiquitination | 3.636567e-5 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 3.735729e-5 |
GO:0010509 | polyamine homeostasis | 3.735729e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 3.776834e-5 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 4.033882e-5 |
GO:0006412 | translation | 4.037232e-5 |
GO:0008298 | intracellular mRNA localization | 4.413462e-5 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 4.692509e-5 |
GO:0006760 | folic acid-containing compound metabolic process | 4.970666e-5 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 5.145410e-5 |
GO:0061157 | mRNA destabilization | 5.145410e-5 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 5.145410e-5 |
GO:0042726 | flavin-containing compound metabolic process | 5.391103e-5 |
GO:0016191 | synaptic vesicle uncoating | 5.743839e-5 |
GO:0050690 | regulation of defense response to virus by virus | 5.823954e-5 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 5.967409e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 7.036182e-5 |
GO:0006413 | translational initiation | 7.112110e-5 |
GO:0045338 | farnesyl diphosphate metabolic process | 7.222632e-5 |
GO:0030037 | actin filament reorganization involved in cell cycle | 7.485870e-5 |
GO:0000296 | spermine transport | 7.485870e-5 |
GO:0005978 | glycogen biosynthetic process | 7.500140e-5 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 7.501695e-5 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 7.759353e-5 |
GO:0071218 | cellular response to misfolded protein | 8.215762e-5 |
GO:0008033 | tRNA processing | 8.620533e-5 |
GO:0014829 | vascular smooth muscle contraction | 8.797245e-5 |
GO:0007130 | synaptonemal complex assembly | 8.905537e-5 |
GO:0032108 | negative regulation of response to nutrient levels | 8.995404e-5 |
GO:0071470 | cellular response to osmotic stress | 8.995404e-5 |
GO:0022038 | corpus callosum development | 9.271884e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 9.313039e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 9.408427e-5 |
GO:0009231 | riboflavin biosynthetic process | 9.666165e-5 |
GO:0033687 | osteoblast proliferation | 1.016292e-4 |
GO:0045217 | cell-cell junction maintenance | 1.080265e-4 |
GO:0051591 | response to cAMP | 1.196524e-4 |
GO:0045838 | positive regulation of membrane potential | 1.242904e-4 |
GO:0042310 | vasoconstriction | 1.264437e-4 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.293278e-4 |
GO:0035356 | cellular triglyceride homeostasis | 1.383481e-4 |
GO:0018277 | protein deamination | 1.383481e-4 |
GO:0070979 | protein K11-linked ubiquitination | 1.436765e-4 |
GO:0060033 | anatomical structure regression | 1.493041e-4 |
GO:0071956 | cellular component maintenance at cellular level | 1.560020e-4 |
GO:0018208 | peptidyl-proline modification | 1.635675e-4 |
GO:0060575 | intestinal epithelial cell differentiation | 1.664073e-4 |
GO:0051066 | dihydrobiopterin metabolic process | 1.716727e-4 |
GO:0045820 | negative regulation of glycolysis | 1.751760e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.774522e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.838063e-4 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.913846e-4 |
GO:0031081 | nuclear pore distribution | 1.998344e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.998344e-4 |
GO:0001682 | tRNA 5'-leader removal | 1.998344e-4 |
GO:0016078 | tRNA catabolic process | 1.998344e-4 |
GO:0043501 | skeletal muscle adaptation | 2.067909e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2.131992e-4 |
GO:0044243 | multicellular organismal catabolic process | 2.291402e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 2.348772e-4 |
GO:0042420 | dopamine catabolic process | 2.412336e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 2.438034e-4 |
GO:0055094 | response to lipoprotein stimulus | 2.522100e-4 |
GO:0055069 | zinc ion homeostasis | 2.561058e-4 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 2.572591e-4 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 2.702377e-4 |
GO:0006414 | translational elongation | 2.742436e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.745307e-4 |
GO:0000046 | autophagic vacuole fusion | 2.745307e-4 |
GO:0035752 | lysosomal lumen pH elevation | 2.745307e-4 |
GO:0001575 | globoside metabolic process | 2.745307e-4 |
GO:0033342 | negative regulation of collagen binding | 2.745307e-4 |
GO:0006457 | protein folding | 2.830521e-4 |
GO:0032581 | ER-dependent peroxisome organization | 2.866905e-4 |
GO:0010266 | response to vitamin B1 | 2.870330e-4 |
GO:0071316 | cellular response to nicotine | 2.930382e-4 |
GO:0010866 | regulation of triglyceride biosynthetic process | 2.966240e-4 |
GO:0034453 | microtubule anchoring | 3.053735e-4 |
GO:0090370 | negative regulation of cholesterol efflux | 3.152049e-4 |
GO:0035873 | lactate transmembrane transport | 3.152049e-4 |
GO:0006546 | glycine catabolic process | 3.566619e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 3.593304e-4 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 3.634489e-4 |
GO:0006390 | transcription from mitochondrial promoter | 3.634489e-4 |
GO:0072376 | protein activation cascade | 3.664417e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 3.748756e-4 |
GO:0034063 | stress granule assembly | 3.828824e-4 |
GO:0070988 | demethylation | 3.891943e-4 |
GO:0006220 | pyrimidine nucleotide metabolic process | 4.241135e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.288423e-4 |
GO:0030574 | collagen catabolic process | 4.377146e-4 |
GO:0006600 | creatine metabolic process | 4.450823e-4 |
GO:0016557 | peroxisome membrane biogenesis | 4.469159e-4 |
GO:0044314 | protein K27-linked ubiquitination | 4.583069e-4 |
GO:0035269 | protein O-linked mannosylation | 4.583069e-4 |
GO:0044342 | type B pancreatic cell proliferation | 4.619930e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 4.619930e-4 |
GO:0030225 | macrophage differentiation | 4.649234e-4 |
GO:0000072 | M phase specific microtubule process | 5.003046e-4 |
GO:0006956 | complement activation | 5.023622e-4 |
GO:0060134 | prepulse inhibition | 5.098999e-4 |
GO:0009264 | deoxyribonucleotide catabolic process | 5.269051e-4 |
GO:0090281 | negative regulation of calcium ion import | 5.278050e-4 |
GO:0071584 | negative regulation of zinc ion import | 5.278050e-4 |
GO:0006584 | catecholamine metabolic process | 5.411242e-4 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 5.449397e-4 |
GO:0060988 | lipid tube assembly | 5.840658e-4 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 5.852085e-4 |
GO:0030539 | male genitalia development | 6.007985e-4 |
GO:0030641 | regulation of cellular pH | 6.089754e-4 |
GO:0008049 | male courtship behavior | 6.238286e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 6.374169e-4 |
GO:0010467 | gene expression | 6.508504e-4 |
GO:0046208 | spermine catabolic process | 6.519430e-4 |
GO:0009712 | catechol-containing compound metabolic process | 6.648835e-4 |
GO:0005980 | glycogen catabolic process | 6.654252e-4 |
GO:0051097 | negative regulation of helicase activity | 6.674419e-4 |
GO:0002071 | glandular epithelial cell maturation | 6.674419e-4 |
GO:0019637 | organophosphate metabolic process | 6.917340e-4 |
GO:0006680 | glucosylceramide catabolic process | 7.014437e-4 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 7.518325e-4 |
GO:0009311 | oligosaccharide metabolic process | 7.648710e-4 |
GO:0042149 | cellular response to glucose starvation | 7.969110e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 8.063263e-4 |
GO:2000210 | positive regulation of anoikis | 8.121339e-4 |
GO:0007042 | lysosomal lumen acidification | 8.121339e-4 |
GO:0090140 | regulation of mitochondrial fission | 8.140629e-4 |
GO:0031167 | rRNA methylation | 8.140629e-4 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 8.409335e-4 |
GO:0071557 | histone H3-K27 demethylation | 8.433150e-4 |
GO:0035574 | histone H4-K20 demethylation | 8.433150e-4 |
GO:0021819 | layer formation in cerebral cortex | 8.433150e-4 |
GO:0006399 | tRNA metabolic process | 8.458267e-4 |
GO:0051532 | regulation of NFAT protein import into nucleus | 8.676753e-4 |
GO:0007021 | tubulin complex assembly | 8.690576e-4 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 8.854096e-4 |
GO:0019348 | dolichol metabolic process | 9.091312e-4 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 9.357752e-4 |
GO:0016242 | negative regulation of macroautophagy | 9.369582e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 9.369582e-4 |
GO:0035094 | response to nicotine | 9.820936e-4 |
GO:0051798 | positive regulation of hair follicle development | 9.848058e-4 |
GO:0046416 | D-amino acid metabolic process | 1.007580e-3 |
GO:0010960 | magnesium ion homeostasis | 1.007580e-3 |
GO:0006505 | GPI anchor metabolic process | 1.038779e-3 |
GO:0046931 | pore complex assembly | 1.041377e-3 |
GO:0071585 | detoxification of cadmium ion | 1.064642e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 1.071328e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 1.088887e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.166283e-3 |
GO:0001958 | endochondral ossification | 1.197681e-3 |
GO:0014888 | striated muscle adaptation | 1.205122e-3 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 1.247580e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 1.285736e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1.285736e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 1.285736e-3 |
GO:0007371 | ventral midline determination | 1.285736e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.302503e-3 |
GO:0032107 | regulation of response to nutrient levels | 1.308093e-3 |
GO:0060911 | cardiac cell fate commitment | 1.365163e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.372482e-3 |
GO:0046839 | phospholipid dephosphorylation | 1.374110e-3 |
GO:0060350 | endochondral bone morphogenesis | 1.461375e-3 |
GO:0009251 | glucan catabolic process | 1.465571e-3 |
GO:0044247 | cellular polysaccharide catabolic process | 1.465571e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.484392e-3 |
GO:0071423 | malate transmembrane transport | 1.484392e-3 |
GO:0015709 | thiosulfate transport | 1.484392e-3 |
GO:0046655 | folic acid metabolic process | 1.522203e-3 |
GO:0007595 | lactation | 1.532561e-3 |
GO:0070173 | regulation of enamel mineralization | 1.557943e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.559793e-3 |
GO:0016598 | protein arginylation | 1.559793e-3 |
GO:0002508 | central tolerance induction | 1.559793e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.559793e-3 |
GO:0048144 | fibroblast proliferation | 1.582911e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.599097e-3 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.599097e-3 |
GO:0007020 | microtubule nucleation | 1.619683e-3 |
GO:0033133 | positive regulation of glucokinase activity | 1.623167e-3 |
GO:0007589 | body fluid secretion | 1.631727e-3 |
GO:0045776 | negative regulation of blood pressure | 1.672448e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.675237e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.682296e-3 |
GO:0042574 | retinal metabolic process | 1.691694e-3 |
GO:2000195 | negative regulation of female gonad development | 1.715938e-3 |
GO:0051788 | response to misfolded protein | 1.840388e-3 |
GO:0070208 | protein heterotrimerization | 1.840979e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 1.853427e-3 |
GO:0006353 | transcription termination, DNA-dependent | 1.855436e-3 |
GO:0008380 | RNA splicing | 1.902716e-3 |
GO:0009957 | epidermal cell fate specification | 1.919867e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.946279e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 1.959936e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.959936e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 1.976573e-3 |
GO:0006982 | response to lipid hydroperoxide | 1.979509e-3 |
GO:0001522 | pseudouridine synthesis | 1.995975e-3 |
GO:2000194 | regulation of female gonad development | 2.003253e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 2.036114e-3 |
GO:0090205 | positive regulation of cholesterol metabolic process | 2.067424e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.071262e-3 |
GO:0021591 | ventricular system development | 2.079451e-3 |
GO:0045218 | zonula adherens maintenance | 2.157255e-3 |
GO:0001983 | baroreceptor response to increased systemic arterial blood pressure | 2.187917e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 2.205324e-3 |
GO:0051412 | response to corticosterone stimulus | 2.205915e-3 |
GO:0046929 | negative regulation of neurotransmitter secretion | 2.220251e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 2.220630e-3 |
GO:0006867 | asparagine transport | 2.220630e-3 |
GO:0006711 | estrogen catabolic process | 2.220630e-3 |
GO:0000088 | mitotic prophase | 2.220630e-3 |
GO:0032836 | glomerular basement membrane development | 2.272205e-3 |
GO:0090344 | negative regulation of cell aging | 2.276865e-3 |
GO:0043687 | post-translational protein modification | 2.363260e-3 |
GO:0071539 | protein localization to centrosome | 2.391614e-3 |
GO:0060375 | regulation of mast cell differentiation | 2.391614e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 2.408707e-3 |
GO:0050908 | detection of light stimulus involved in visual perception | 2.447748e-3 |
GO:0051454 | intracellular pH elevation | 2.462757e-3 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 2.462757e-3 |
GO:0060741 | prostate gland stromal morphogenesis | 2.470646e-3 |
GO:0048014 | Tie receptor signaling pathway | 2.470646e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 2.519058e-3 |
GO:0006544 | glycine metabolic process | 2.519640e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.600129e-3 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 2.690971e-3 |
GO:0006958 | complement activation, classical pathway | 2.748737e-3 |
GO:0043241 | protein complex disassembly | 2.791634e-3 |
GO:0000726 | non-recombinational repair | 2.820053e-3 |
GO:0042559 | pteridine-containing compound biosynthetic process | 2.839273e-3 |
GO:0042417 | dopamine metabolic process | 2.860811e-3 |
GO:0005977 | glycogen metabolic process | 2.901587e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 2.907576e-3 |
GO:0006562 | proline catabolic process | 2.907576e-3 |
GO:0070192 | chromosome organization involved in meiosis | 2.939995e-3 |
GO:0090042 | tubulin deacetylation | 2.981519e-3 |
GO:0070846 | Hsp90 deacetylation | 2.981519e-3 |
GO:0003094 | glomerular filtration | 2.981519e-3 |
GO:0042305 | specification of segmental identity, mandibular segment | 2.981519e-3 |
GO:0021592 | fourth ventricle development | 3.015098e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 3.048157e-3 |
GO:0034436 | glycoprotein transport | 3.050495e-3 |
GO:0009720 | detection of hormone stimulus | 3.050495e-3 |
GO:0006598 | polyamine catabolic process | 3.050495e-3 |
GO:0090234 | regulation of kinetochore assembly | 3.085933e-3 |
GO:0090169 | regulation of spindle assembly | 3.085933e-3 |
GO:0008299 | isoprenoid biosynthetic process | 3.089033e-3 |
GO:0071577 | zinc ion transmembrane transport | 3.117547e-3 |
GO:0010669 | epithelial structure maintenance | 3.135084e-3 |
GO:0060343 | trabecula formation | 3.159938e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 3.184234e-3 |
GO:0007131 | reciprocal meiotic recombination | 3.207755e-3 |
GO:0055078 | sodium ion homeostasis | 3.357096e-3 |
GO:0042989 | sequestering of actin monomers | 3.397127e-3 |
GO:0009235 | cobalamin metabolic process | 3.450781e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 3.457538e-3 |
GO:0031668 | cellular response to extracellular stimulus | 3.460608e-3 |
GO:0000154 | rRNA modification | 3.654464e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 3.671622e-3 |
GO:0007100 | mitotic centrosome separation | 3.671622e-3 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 3.693278e-3 |
GO:0010039 | response to iron ion | 3.721161e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 3.726514e-3 |
GO:0046855 | inositol phosphate dephosphorylation | 3.763489e-3 |
GO:0061383 | trabecula morphogenesis | 3.802044e-3 |
GO:0007141 | male meiosis I | 3.906099e-3 |
GO:0008654 | phospholipid biosynthetic process | 3.966624e-3 |
GO:0006678 | glucosylceramide metabolic process | 3.994748e-3 |
GO:0071545 | inositol phosphate catabolic process | 4.023980e-3 |
GO:0071897 | DNA biosynthetic process | 4.148785e-3 |
GO:0006644 | phospholipid metabolic process | 4.158591e-3 |
GO:0055014 | atrial cardiac muscle cell development | 4.172392e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 4.187425e-3 |
GO:0007006 | mitochondrial membrane organization | 4.203898e-3 |
GO:0006103 | 2-oxoglutarate metabolic process | 4.234652e-3 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 4.517260e-3 |
GO:0042053 | regulation of dopamine metabolic process | 4.553846e-3 |
GO:0060179 | male mating behavior | 4.554489e-3 |
GO:0006073 | cellular glucan metabolic process | 4.554542e-3 |
GO:0010458 | exit from mitosis | 4.634264e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 4.650743e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 4.712183e-3 |
GO:0001885 | endothelial cell development | 4.719495e-3 |
GO:0045919 | positive regulation of cytolysis | 4.740630e-3 |
GO:0023021 | termination of signal transduction | 4.740630e-3 |
GO:0034421 | post-translational protein acetylation | 4.759524e-3 |
GO:0008215 | spermine metabolic process | 4.806616e-3 |
GO:0014916 | regulation of lung blood pressure | 4.937796e-3 |
GO:0070076 | histone lysine demethylation | 4.969015e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.102478e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 5.265869e-3 |
GO:0061298 | retina vasculature development in camera-type eye | 5.274367e-3 |
GO:0030259 | lipid glycosylation | 5.274367e-3 |
GO:0010888 | negative regulation of lipid storage | 5.275210e-3 |
GO:0042424 | catecholamine catabolic process | 5.311225e-3 |
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 5.311225e-3 |
GO:0034120 | positive regulation of erythrocyte aggregation | 5.408919e-3 |
GO:0030488 | tRNA methylation | 5.408919e-3 |
GO:0010070 | zygote asymmetric cell division | 5.498330e-3 |
GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway | 5.498330e-3 |
GO:0006939 | smooth muscle contraction | 5.531304e-3 |
GO:0010954 | positive regulation of protein processing | 5.710786e-3 |
GO:0009163 | nucleoside biosynthetic process | 5.757500e-3 |
GO:2000074 | regulation of type B pancreatic cell development | 5.780857e-3 |
GO:0000239 | pachytene | 5.854925e-3 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 5.863239e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 5.863239e-3 |
GO:0035026 | leading edge cell differentiation | 5.863239e-3 |
GO:0072224 | metanephric glomerulus development | 5.921943e-3 |
GO:0002121 | inter-male aggressive behavior | 5.945288e-3 |
GO:0032963 | collagen metabolic process | 5.975104e-3 |
GO:0051299 | centrosome separation | 5.989027e-3 |
GO:0061028 | establishment of endothelial barrier | 6.088721e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 6.128019e-3 |
GO:0050434 | positive regulation of viral transcription | 6.480274e-3 |
GO:0090224 | regulation of spindle organization | 6.515781e-3 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 6.516935e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 6.525283e-3 |
GO:0016074 | snoRNA metabolic process | 6.545148e-3 |
GO:0002238 | response to molecule of fungal origin | 6.757164e-3 |
GO:0045684 | positive regulation of epidermis development | 6.771939e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 6.815906e-3 |
GO:0006783 | heme biosynthetic process | 6.876588e-3 |
GO:0006446 | regulation of translational initiation | 6.987616e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 7.180881e-3 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 7.180881e-3 |
GO:0070179 | D-serine biosynthetic process | 7.235818e-3 |
GO:0006713 | glucocorticoid catabolic process | 7.235818e-3 |
GO:0046629 | gamma-delta T cell activation | 7.235818e-3 |
GO:0046952 | ketone body catabolic process | 7.287246e-3 |
GO:0031643 | positive regulation of myelination | 7.287246e-3 |
GO:0035418 | protein localization to synapse | 7.402258e-3 |
GO:0097070 | ductus arteriosus closure | 7.405612e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 7.454640e-3 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 7.454640e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 7.454640e-3 |
GO:0051660 | establishment of centrosome localization | 7.613276e-3 |
GO:0071335 | hair follicle cell proliferation | 7.613276e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 7.613276e-3 |
GO:0032290 | peripheral nervous system myelin formation | 7.613276e-3 |
GO:0021540 | corpus callosum morphogenesis | 7.613276e-3 |
GO:0033131 | regulation of glucokinase activity | 7.679649e-3 |
GO:0032096 | negative regulation of response to food | 7.858786e-3 |
GO:0071347 | cellular response to interleukin-1 | 7.876596e-3 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 7.893492e-3 |
GO:0006281 | DNA repair | 7.944228e-3 |
GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 7.960198e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 8.047586e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 8.104123e-3 |
GO:0002070 | epithelial cell maturation | 8.177393e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 8.368898e-3 |
GO:0007228 | positive regulation of hh target transcription factor activity | 8.421595e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 8.421595e-3 |
GO:0070682 | proteasome regulatory particle assembly | 8.497839e-3 |
GO:0015878 | biotin transport | 8.497839e-3 |
GO:0015887 | pantothenate transmembrane transport | 8.497839e-3 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 8.682559e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 8.714229e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 8.720418e-3 |
GO:0051956 | negative regulation of amino acid transport | 8.863571e-3 |
GO:0006072 | glycerol-3-phosphate metabolic process | 8.863571e-3 |
GO:0003009 | skeletal muscle contraction | 8.984152e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 9.016167e-3 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 9.016167e-3 |
GO:0014044 | Schwann cell development | 9.016522e-3 |
GO:0044260 | cellular macromolecule metabolic process | 9.036346e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 9.040804e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 9.184839e-3 |
GO:0071415 | cellular response to purine-containing compound | 9.229899e-3 |
GO:0060356 | leucine import | 9.229899e-3 |
GO:0033299 | secretion of lysosomal enzymes | 9.341597e-3 |
GO:0003289 | atrial septum primum morphogenesis | 9.350822e-3 |
GO:0016926 | protein desumoylation | 9.366377e-3 |
GO:0010934 | macrophage cytokine production | 9.366377e-3 |
GO:0021670 | lateral ventricle development | 9.381933e-3 |
GO:0071168 | protein localization to chromatin | 9.387732e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 9.387732e-3 |
GO:0070193 | synaptonemal complex organization | 9.509853e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 9.561728e-3 |
GO:0042401 | cellular biogenic amine biosynthetic process | 9.645253e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 9.663296e-3 |
GO:0051926 | negative regulation of calcium ion transport | 9.698239e-3 |
GO:0009267 | cellular response to starvation | 9.833332e-3 |
GO:0001964 | startle response | 9.879976e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 9.899817e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 9.968200e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 9.990907e-3 |
GO:0032922 | circadian regulation of gene expression | 1.005507e-2 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.005507e-2 |
GO:0007017 | microtubule-based process | 1.017751e-2 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 1.019317e-2 |
GO:0051324 | prophase | 1.021741e-2 |
GO:0032741 | positive regulation of interleukin-18 production | 1.032657e-2 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 1.067512e-2 |
GO:0002922 | positive regulation of humoral immune response | 1.082827e-2 |
GO:0007612 | learning | 1.088200e-2 |
GO:0048537 | mucosal-associated lymphoid tissue development | 1.089406e-2 |
GO:0048312 | intracellular distribution of mitochondria | 1.107624e-2 |
GO:0042594 | response to starvation | 1.110988e-2 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 1.120886e-2 |
GO:0007129 | synapsis | 1.136064e-2 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.136758e-2 |
GO:0071034 | CUT catabolic process | 1.137793e-2 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.137793e-2 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 1.137793e-2 |
GO:0010994 | free ubiquitin chain polymerization | 1.137793e-2 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 1.143315e-2 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.145193e-2 |
GO:0051182 | coenzyme transport | 1.158275e-2 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.169125e-2 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.169125e-2 |
GO:0035967 | cellular response to topologically incorrect protein | 1.177923e-2 |
GO:0031915 | positive regulation of synaptic plasticity | 1.185044e-2 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.186465e-2 |
GO:0006450 | regulation of translational fidelity | 1.211889e-2 |
GO:0046548 | retinal rod cell development | 1.217206e-2 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 1.231192e-2 |
GO:0018205 | peptidyl-lysine modification | 1.235944e-2 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 1.249735e-2 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.253103e-2 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1.255663e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.276965e-2 |
GO:0071169 | establishment of protein localization to chromatin | 1.298724e-2 |
GO:0018364 | peptidyl-glutamine methylation | 1.298724e-2 |
GO:0051955 | regulation of amino acid transport | 1.299639e-2 |
GO:0009396 | folic acid-containing compound biosynthetic process | 1.299639e-2 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.305308e-2 |
GO:0014037 | Schwann cell differentiation | 1.306492e-2 |
GO:0032648 | regulation of interferon-beta production | 1.307971e-2 |
GO:0060823 | canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 1.336924e-2 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1.339837e-2 |
GO:0019985 | translesion synthesis | 1.339966e-2 |
GO:0006447 | regulation of translational initiation by iron | 1.339966e-2 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 1.357977e-2 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.358319e-2 |
GO:0006301 | postreplication repair | 1.359439e-2 |
GO:0048712 | negative regulation of astrocyte differentiation | 1.373906e-2 |
GO:2000209 | regulation of anoikis | 1.384638e-2 |
GO:0060464 | lung lobe formation | 1.389821e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034660 | ncRNA metabolic process | 3.513354e-13 |
GO:0070179 | D-serine biosynthetic process | 1.344938e-9 |
GO:0046092 | deoxycytidine metabolic process | 2.319410e-9 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 3.610692e-9 |
GO:0006396 | RNA processing | 7.211250e-9 |
GO:0015876 | acetyl-CoA transport | 1.037397e-8 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.288285e-8 |
GO:0046038 | GMP catabolic process | 6.908640e-8 |
GO:0032264 | IMP salvage | 6.908640e-8 |
GO:0006178 | guanine salvage | 6.908640e-8 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 6.908640e-8 |
GO:0032263 | GMP salvage | 6.908640e-8 |
GO:0097029 | mature dendritic cell differentiation | 9.163527e-8 |
GO:0006168 | adenine salvage | 9.274065e-8 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.510903e-7 |
GO:0006413 | translational initiation | 1.659927e-7 |
GO:0000910 | cytokinesis | 1.763998e-7 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.023164e-7 |
GO:0016072 | rRNA metabolic process | 2.097748e-7 |
GO:0016926 | protein desumoylation | 2.114559e-7 |
GO:0071044 | histone mRNA catabolic process | 2.784500e-7 |
GO:0006364 | rRNA processing | 3.187692e-7 |
GO:0043096 | purine base salvage | 3.441550e-7 |
GO:0034470 | ncRNA processing | 3.802093e-7 |
GO:0046416 | D-amino acid metabolic process | 4.051146e-7 |
GO:0006975 | DNA damage induced protein phosphorylation | 4.118154e-7 |
GO:0042396 | phosphagen biosynthetic process | 4.824685e-7 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 9.338415e-7 |
GO:0008334 | histone mRNA metabolic process | 1.006776e-6 |
GO:0043103 | hypoxanthine salvage | 1.030416e-6 |
GO:0032261 | purine nucleotide salvage | 1.030416e-6 |
GO:0045884 | regulation of survival gene product expression | 1.470474e-6 |
GO:0090304 | nucleic acid metabolic process | 1.581065e-6 |
GO:0006402 | mRNA catabolic process | 2.368182e-6 |
GO:0009113 | purine base biosynthetic process | 2.406231e-6 |
GO:0006188 | IMP biosynthetic process | 3.111868e-6 |
GO:0010454 | negative regulation of cell fate commitment | 3.347027e-6 |
GO:0046129 | purine ribonucleoside biosynthetic process | 3.505112e-6 |
GO:0042660 | positive regulation of cell fate specification | 4.107492e-6 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 4.376703e-6 |
GO:0060299 | negative regulation of sarcomere organization | 4.376703e-6 |
GO:0010467 | gene expression | 4.776172e-6 |
GO:0045964 | positive regulation of dopamine metabolic process | 5.086967e-6 |
GO:0042278 | purine nucleoside metabolic process | 5.237265e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.252109e-6 |
GO:0002663 | positive regulation of B cell tolerance induction | 5.559956e-6 |
GO:0043558 | regulation of translational initiation in response to stress | 5.797944e-6 |
GO:0000279 | M phase | 5.999014e-6 |
GO:0006020 | inositol metabolic process | 6.640304e-6 |
GO:0051583 | dopamine uptake | 7.902075e-6 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 9.149336e-6 |
GO:0006399 | tRNA metabolic process | 1.011517e-5 |
GO:0035269 | protein O-linked mannosylation | 1.090822e-5 |
GO:0009996 | negative regulation of cell fate specification | 1.215555e-5 |
GO:0042254 | ribosome biogenesis | 1.296039e-5 |
GO:0060658 | nipple morphogenesis | 1.334524e-5 |
GO:0033120 | positive regulation of RNA splicing | 1.383367e-5 |
GO:0046548 | retinal rod cell development | 1.430180e-5 |
GO:0006412 | translation | 1.508465e-5 |
GO:0006401 | RNA catabolic process | 1.632935e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.017387e-5 |
GO:0071034 | CUT catabolic process | 2.167464e-5 |
GO:0055078 | sodium ion homeostasis | 2.195571e-5 |
GO:0034587 | piRNA metabolic process | 2.413155e-5 |
GO:0046314 | phosphocreatine biosynthetic process | 2.473011e-5 |
GO:0034635 | glutathione transport | 2.473011e-5 |
GO:0006177 | GMP biosynthetic process | 2.586409e-5 |
GO:0032859 | activation of Ral GTPase activity | 2.601378e-5 |
GO:0019673 | GDP-mannose metabolic process | 2.725984e-5 |
GO:0033240 | positive regulation of cellular amine metabolic process | 2.749805e-5 |
GO:0009116 | nucleoside metabolic process | 2.900237e-5 |
GO:0046128 | purine ribonucleoside metabolic process | 2.907631e-5 |
GO:0048047 | mating behavior, sex discrimination | 2.961094e-5 |
GO:0002124 | territorial aggressive behavior | 2.961094e-5 |
GO:0006281 | DNA repair | 3.140680e-5 |
GO:0051301 | cell division | 3.436252e-5 |
GO:0043526 | neuroprotection | 3.564953e-5 |
GO:0072608 | interleukin-10 secretion | 3.669991e-5 |
GO:0072643 | interferon-gamma secretion | 3.669991e-5 |
GO:0090198 | negative regulation of chemokine secretion | 3.669991e-5 |
GO:0070963 | positive regulation of neutrophil mediated killing of gram-negative bacterium | 3.669991e-5 |
GO:0048291 | isotype switching to IgG isotypes | 3.669991e-5 |
GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 3.669991e-5 |
GO:0002368 | B cell cytokine production | 3.669991e-5 |
GO:0043311 | positive regulation of eosinophil degranulation | 3.669991e-5 |
GO:0048143 | astrocyte activation | 3.951034e-5 |
GO:0042866 | pyruvate biosynthetic process | 4.041581e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 4.400770e-5 |
GO:0061351 | neural precursor cell proliferation | 4.833600e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 5.180202e-5 |
GO:0090083 | regulation of inclusion body assembly | 5.508693e-5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 5.594829e-5 |
GO:0008616 | queuosine biosynthetic process | 5.594829e-5 |
GO:0002897 | positive regulation of central B cell tolerance induction | 5.594829e-5 |
GO:0002508 | central tolerance induction | 5.594829e-5 |
GO:0043173 | nucleotide salvage | 5.880923e-5 |
GO:0019348 | dolichol metabolic process | 5.880923e-5 |
GO:0009119 | ribonucleoside metabolic process | 5.892181e-5 |
GO:0006259 | DNA metabolic process | 5.974549e-5 |
GO:0001732 | formation of translation initiation complex | 6.103996e-5 |
GO:0030836 | positive regulation of actin filament depolymerization | 7.960769e-5 |
GO:0006561 | proline biosynthetic process | 8.492802e-5 |
GO:0043101 | purine-containing compound salvage | 8.521498e-5 |
GO:0007099 | centriole replication | 9.673724e-5 |
GO:0016574 | histone ubiquitination | 9.741398e-5 |
GO:0018293 | protein-FAD linkage | 1.053137e-4 |
GO:0032782 | bile acid secretion | 1.053137e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.053137e-4 |
GO:0003096 | renal sodium ion transport | 1.053137e-4 |
GO:0006166 | purine ribonucleoside salvage | 1.105273e-4 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1.204505e-4 |
GO:0019236 | response to pheromone | 1.259972e-4 |
GO:0044260 | cellular macromolecule metabolic process | 1.303322e-4 |
GO:0060911 | cardiac cell fate commitment | 1.354308e-4 |
GO:0097028 | dendritic cell differentiation | 1.662206e-4 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 1.706973e-4 |
GO:0071480 | cellular response to gamma radiation | 1.841305e-4 |
GO:0017148 | negative regulation of translation | 1.964503e-4 |
GO:0030032 | lamellipodium assembly | 2.099546e-4 |
GO:0009452 | RNA capping | 2.325753e-4 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.505974e-4 |
GO:0006408 | snRNA export from nucleus | 2.683727e-4 |
GO:0032836 | glomerular basement membrane development | 2.735985e-4 |
GO:0016070 | RNA metabolic process | 2.779477e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 2.794449e-4 |
GO:0044314 | protein K27-linked ubiquitination | 2.810105e-4 |
GO:0042851 | L-alanine metabolic process | 2.810105e-4 |
GO:0016601 | Rac protein signal transduction | 2.834509e-4 |
GO:0051712 | positive regulation of killing of cells of other organism | 2.891149e-4 |
GO:0061084 | negative regulation of protein refolding | 3.051710e-4 |
GO:0006407 | rRNA export from nucleus | 3.051710e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 3.053190e-4 |
GO:0006476 | protein deacetylation | 3.429783e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 3.458036e-4 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 3.490198e-4 |
GO:0046112 | nucleobase biosynthetic process | 3.553715e-4 |
GO:0045885 | positive regulation of survival gene product expression | 3.587808e-4 |
GO:0051029 | rRNA transport | 3.614927e-4 |
GO:0035601 | protein deacylation | 3.640045e-4 |
GO:0035519 | protein K29-linked ubiquitination | 3.890369e-4 |
GO:0050775 | positive regulation of dendrite morphogenesis | 4.124281e-4 |
GO:0045040 | protein import into mitochondrial outer membrane | 4.257554e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 4.441456e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.496572e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 4.496572e-4 |
GO:0010960 | magnesium ion homeostasis | 4.496572e-4 |
GO:0007356 | thorax and anterior abdomen determination | 4.496572e-4 |
GO:0070318 | positive regulation of G0 to G1 transition | 4.624874e-4 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 4.624874e-4 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 4.624874e-4 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 5.162013e-4 |
GO:0031081 | nuclear pore distribution | 5.162013e-4 |
GO:0000238 | zygotene | 5.162013e-4 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 6.133870e-4 |
GO:2000781 | positive regulation of double-strand break repair | 6.133870e-4 |
GO:0006021 | inositol biosynthetic process | 6.133870e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 6.133870e-4 |
GO:0010155 | regulation of proton transport | 6.197484e-4 |
GO:0008634 | negative regulation of survival gene product expression | 6.402572e-4 |
GO:0070914 | UV-damage excision repair | 6.513385e-4 |
GO:0002635 | negative regulation of germinal center formation | 6.513385e-4 |
GO:0072054 | renal outer medulla development | 6.639052e-4 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 6.815590e-4 |
GO:0007060 | male meiosis chromosome segregation | 6.815590e-4 |
GO:0051586 | positive regulation of dopamine uptake | 6.965623e-4 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 6.965623e-4 |
GO:0072006 | nephron development | 7.396888e-4 |
GO:0014812 | muscle cell migration | 7.509743e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 7.710137e-4 |
GO:0070584 | mitochondrion morphogenesis | 8.105443e-4 |
GO:0031274 | positive regulation of pseudopodium assembly | 8.151509e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 8.165398e-4 |
GO:0009948 | anterior/posterior axis specification | 8.339551e-4 |
GO:0006310 | DNA recombination | 8.417478e-4 |
GO:0045947 | negative regulation of translational initiation | 8.439229e-4 |
GO:0060359 | response to ammonium ion | 8.785385e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 8.817838e-4 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 8.817838e-4 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 8.817838e-4 |
GO:0008208 | C21-steroid hormone catabolic process | 9.167745e-4 |
GO:0046103 | inosine biosynthetic process | 9.167745e-4 |
GO:0006154 | adenosine catabolic process | 9.167745e-4 |
GO:0008652 | cellular amino acid biosynthetic process | 9.198512e-4 |
GO:0072053 | renal inner medulla development | 9.515773e-4 |
GO:0060011 | Sertoli cell proliferation | 9.515773e-4 |
GO:0043555 | regulation of translation in response to stress | 9.515773e-4 |
GO:0006807 | nitrogen compound metabolic process | 9.585360e-4 |
GO:0007049 | cell cycle | 9.768077e-4 |
GO:0045792 | negative regulation of cell size | 9.953348e-4 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 1.037735e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.039433e-3 |
GO:0010661 | positive regulation of muscle cell apoptosis | 1.064505e-3 |
GO:0046434 | organophosphate catabolic process | 1.193635e-3 |
GO:0060214 | endocardium formation | 1.218067e-3 |
GO:0044088 | regulation of vacuole organization | 1.223951e-3 |
GO:0035621 | ER to Golgi ceramide transport | 1.223951e-3 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 1.253203e-3 |
GO:0016142 | O-glycoside catabolic process | 1.268187e-3 |
GO:0055062 | phosphate ion homeostasis | 1.296425e-3 |
GO:0009744 | response to sucrose stimulus | 1.338312e-3 |
GO:0051451 | myoblast migration | 1.376042e-3 |
GO:0060439 | trachea morphogenesis | 1.423677e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 1.436729e-3 |
GO:0033182 | regulation of histone ubiquitination | 1.460176e-3 |
GO:0006258 | UDP-glucose catabolic process | 1.460176e-3 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 1.460176e-3 |
GO:0033627 | cell adhesion mediated by integrin | 1.470673e-3 |
GO:0014047 | glutamate secretion | 1.470673e-3 |
GO:0031272 | regulation of pseudopodium assembly | 1.470673e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.483872e-3 |
GO:0032930 | positive regulation of superoxide anion generation | 1.483872e-3 |
GO:0070534 | protein K63-linked ubiquitination | 1.494650e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.518460e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.590440e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.592151e-3 |
GO:0008617 | guanosine metabolic process | 1.592151e-3 |
GO:0051182 | coenzyme transport | 1.626555e-3 |
GO:0060434 | bronchus morphogenesis | 1.626555e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.626555e-3 |
GO:0007067 | mitosis | 1.769469e-3 |
GO:0048285 | organelle fission | 1.853873e-3 |
GO:0070316 | regulation of G0 to G1 transition | 1.893762e-3 |
GO:0007212 | dopamine receptor signaling pathway | 1.894275e-3 |
GO:0022402 | cell cycle process | 1.981564e-3 |
GO:0000087 | M phase of mitotic cell cycle | 2.011344e-3 |
GO:0010390 | histone monoubiquitination | 2.026535e-3 |
GO:0015872 | dopamine transport | 2.050507e-3 |
GO:0010453 | regulation of cell fate commitment | 2.054893e-3 |
GO:0042026 | protein refolding | 2.062832e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 2.067682e-3 |
GO:0006883 | cellular sodium ion homeostasis | 2.152044e-3 |
GO:2000043 | regulation of cardiac cell fate specification | 2.156742e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.156742e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 2.156742e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 2.172852e-3 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 2.179529e-3 |
GO:0071279 | cellular response to cobalt ion | 2.182099e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 2.182099e-3 |
GO:0072334 | UDP-galactose transmembrane transport | 2.182099e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 2.182099e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 2.182099e-3 |
GO:0032835 | glomerulus development | 2.183651e-3 |
GO:0060492 | lung induction | 2.353814e-3 |
GO:0060452 | positive regulation of cardiac muscle contraction | 2.353814e-3 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 2.399739e-3 |
GO:0051030 | snRNA transport | 2.411869e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 2.411869e-3 |
GO:0000492 | box C/D snoRNP assembly | 2.411869e-3 |
GO:0046102 | inosine metabolic process | 2.411869e-3 |
GO:0034227 | tRNA thio-modification | 2.557794e-3 |
GO:0060433 | bronchus development | 2.581704e-3 |
GO:0042178 | xenobiotic catabolic process | 2.671193e-3 |
GO:0030517 | negative regulation of axon extension | 2.672018e-3 |
GO:0051588 | regulation of neurotransmitter transport | 2.682321e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.701889e-3 |
GO:0072107 | positive regulation of ureteric bud formation | 2.802746e-3 |
GO:0002098 | tRNA wobble uridine modification | 2.818816e-3 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 2.934133e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 2.934133e-3 |
GO:0016567 | protein ubiquitination | 2.957492e-3 |
GO:0060375 | regulation of mast cell differentiation | 2.959729e-3 |
GO:0048840 | otolith development | 2.959729e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 2.967876e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 2.973113e-3 |
GO:0010894 | negative regulation of steroid biosynthetic process | 2.974239e-3 |
GO:0072050 | S-shaped body morphogenesis | 2.984284e-3 |
GO:0072049 | comma-shaped body morphogenesis | 2.984284e-3 |
GO:0006599 | phosphagen metabolic process | 2.984284e-3 |
GO:0000226 | microtubule cytoskeleton organization | 3.035610e-3 |
GO:0042733 | embryonic digit morphogenesis | 3.071102e-3 |
GO:0007405 | neuroblast proliferation | 3.096263e-3 |
GO:0008595 | anterior/posterior axis specification, embryo | 3.189749e-3 |
GO:0007131 | reciprocal meiotic recombination | 3.245104e-3 |
GO:0001842 | neural fold formation | 3.253233e-3 |
GO:0043094 | cellular metabolic compound salvage | 3.283231e-3 |
GO:0006144 | purine base metabolic process | 3.295860e-3 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 3.373662e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 3.411752e-3 |
GO:0051865 | protein autoubiquitination | 3.457770e-3 |
GO:0046676 | negative regulation of insulin secretion | 3.467541e-3 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 3.605239e-3 |
GO:0006429 | leucyl-tRNA aminoacylation | 3.605239e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 3.635145e-3 |
GO:0006560 | proline metabolic process | 3.635145e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 3.644240e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 3.644240e-3 |
GO:0043973 | histone H3-K4 acetylation | 3.644240e-3 |
GO:0006601 | creatine biosynthetic process | 3.644240e-3 |
GO:0001788 | antibody-dependent cellular cytotoxicity | 3.644240e-3 |
GO:0019376 | galactolipid catabolic process | 3.657551e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 3.727928e-3 |
GO:0048639 | positive regulation of developmental growth | 3.735197e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.736026e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 3.782344e-3 |
GO:0031581 | hemidesmosome assembly | 3.923033e-3 |
GO:0060047 | heart contraction | 3.939202e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 4.037864e-3 |
GO:0030516 | regulation of axon extension | 4.070816e-3 |
GO:0050768 | negative regulation of neurogenesis | 4.313137e-3 |
GO:0051298 | centrosome duplication | 4.422314e-3 |
GO:0060033 | anatomical structure regression | 4.452445e-3 |
GO:0022403 | cell cycle phase | 4.455921e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 4.467662e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4.492768e-3 |
GO:0002645 | positive regulation of tolerance induction | 4.520662e-3 |
GO:0042559 | pteridine-containing compound biosynthetic process | 4.522388e-3 |
GO:0006513 | protein monoubiquitination | 4.570359e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 4.596355e-3 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 4.596355e-3 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 4.667951e-3 |
GO:0043628 | ncRNA 3'-end processing | 4.667951e-3 |
GO:0015886 | heme transport | 4.705071e-3 |
GO:0060523 | prostate epithelial cord elongation | 4.784056e-3 |
GO:0007098 | centrosome cycle | 4.907254e-3 |
GO:0046716 | muscle cell homeostasis | 5.151782e-3 |
GO:0007051 | spindle organization | 5.207097e-3 |
GO:0070194 | synaptonemal complex disassembly | 5.243198e-3 |
GO:0040040 | thermosensory behavior | 5.243198e-3 |
GO:0043309 | regulation of eosinophil degranulation | 5.243198e-3 |
GO:0007625 | grooming behavior | 5.248599e-3 |
GO:0061324 | canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation | 5.368776e-3 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 5.368776e-3 |
GO:0014909 | smooth muscle cell migration | 5.368776e-3 |
GO:0022617 | extracellular matrix disassembly | 5.374266e-3 |
GO:0043687 | post-translational protein modification | 5.457958e-3 |
GO:0030031 | cell projection assembly | 5.467529e-3 |
GO:0006290 | pyrimidine dimer repair | 5.612039e-3 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 5.621587e-3 |
GO:0016191 | synaptic vesicle uncoating | 5.621587e-3 |
GO:0003142 | cardiogenic plate morphogenesis | 5.621587e-3 |
GO:0001828 | inner cell mass cellular morphogenesis | 5.621587e-3 |
GO:0033523 | histone H2B ubiquitination | 5.647432e-3 |
GO:0021575 | hindbrain morphogenesis | 5.684021e-3 |
GO:0090196 | regulation of chemokine secretion | 5.776450e-3 |
GO:0016554 | cytidine to uridine editing | 5.828503e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.828503e-3 |
GO:0042417 | dopamine metabolic process | 5.876967e-3 |
GO:0034505 | tooth mineralization | 5.934982e-3 |
GO:0060535 | trachea cartilage morphogenesis | 6.059094e-3 |
GO:0034329 | cell junction assembly | 6.159642e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 6.161436e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 6.212653e-3 |
GO:0007044 | cell-substrate junction assembly | 6.226047e-3 |
GO:0002921 | negative regulation of humoral immune response | 6.261851e-3 |
GO:0060737 | prostate gland morphogenetic growth | 6.261851e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 6.261851e-3 |
GO:0072210 | metanephric nephron development | 6.359049e-3 |
GO:0051292 | nuclear pore complex assembly | 6.404597e-3 |
GO:0032092 | positive regulation of protein binding | 6.439945e-3 |
GO:0008033 | tRNA processing | 6.454278e-3 |
GO:0060081 | membrane hyperpolarization | 6.512958e-3 |
GO:0060972 | left/right pattern formation | 6.649088e-3 |
GO:0090278 | negative regulation of peptide hormone secretion | 6.737829e-3 |
GO:0045773 | positive regulation of axon extension | 6.804865e-3 |
GO:0030011 | maintenance of cell polarity | 6.885944e-3 |
GO:0014002 | astrocyte development | 6.951671e-3 |
GO:0002021 | response to dietary excess | 6.951671e-3 |
GO:0006603 | phosphocreatine metabolic process | 7.014835e-3 |
GO:0002651 | positive regulation of tolerance induction to self antigen | 7.014835e-3 |
GO:0009059 | macromolecule biosynthetic process | 7.073443e-3 |
GO:2000507 | positive regulation of energy homeostasis | 7.083564e-3 |
GO:2000253 | positive regulation of feeding behavior | 7.083564e-3 |
GO:0051668 | localization within membrane | 7.137199e-3 |
GO:0019047 | provirus integration | 7.142905e-3 |
GO:0030328 | prenylcysteine catabolic process | 7.142905e-3 |
GO:0016140 | O-glycoside metabolic process | 7.142905e-3 |
GO:0006431 | methionyl-tRNA aminoacylation | 7.142905e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 7.142905e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 7.142905e-3 |
GO:0071545 | inositol phosphate catabolic process | 7.147587e-3 |
GO:0032099 | negative regulation of appetite | 7.147587e-3 |
GO:0032446 | protein modification by small protein conjugation | 7.330239e-3 |
GO:0000105 | histidine biosynthetic process | 7.465833e-3 |
GO:0031047 | gene silencing by RNA | 7.558566e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 7.879402e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 7.879402e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 7.879402e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 7.879402e-3 |
GO:0022615 | protein to membrane docking | 7.879402e-3 |
GO:0048677 | axon extension involved in regeneration | 7.879402e-3 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 7.879402e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 7.895550e-3 |
GO:0006809 | nitric oxide biosynthetic process | 7.895550e-3 |
GO:0006563 | L-serine metabolic process | 7.895550e-3 |
GO:0030261 | chromosome condensation | 8.132342e-3 |
GO:0050658 | RNA transport | 8.149287e-3 |
GO:0032535 | regulation of cellular component size | 8.164971e-3 |
GO:0032096 | negative regulation of response to food | 8.285690e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 8.285690e-3 |
GO:0060649 | mammary gland bud elongation | 8.351392e-3 |
GO:0060659 | nipple sheath formation | 8.351392e-3 |
GO:2000778 | positive regulation of interleukin-6 secretion | 8.351392e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 8.351392e-3 |
GO:0006428 | isoleucyl-tRNA aminoacylation | 8.351392e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 8.351392e-3 |
GO:2000505 | regulation of energy homeostasis | 8.435999e-3 |
GO:0002524 | hypersensitivity | 8.435999e-3 |
GO:0009164 | nucleoside catabolic process | 8.507646e-3 |
GO:0007076 | mitotic chromosome condensation | 8.507646e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 8.530873e-3 |
GO:0031125 | rRNA 3'-end processing | 8.530873e-3 |
GO:0000053 | argininosuccinate metabolic process | 8.592571e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 8.592571e-3 |
GO:0071539 | protein localization to centrosome | 8.592571e-3 |
GO:0010878 | cholesterol storage | 8.592571e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 9.020503e-3 |
GO:0046032 | ADP catabolic process | 9.020503e-3 |
GO:0046709 | IDP catabolic process | 9.020503e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 9.058715e-3 |
GO:0001895 | retina homeostasis | 9.104239e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 9.114505e-3 |
GO:0046931 | pore complex assembly | 9.114505e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 9.114505e-3 |
GO:0007008 | outer mitochondrial membrane organization | 9.270130e-3 |
GO:0010721 | negative regulation of cell development | 9.281535e-3 |
GO:0006260 | DNA replication | 9.594940e-3 |
GO:0060215 | primitive hemopoiesis | 9.645436e-3 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 9.645436e-3 |
GO:0055075 | potassium ion homeostasis | 9.764487e-3 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 9.825347e-3 |
GO:0045927 | positive regulation of growth | 1.016052e-2 |
GO:0032349 | positive regulation of aldosterone biosynthetic process | 1.021846e-2 |
GO:0060539 | diaphragm development | 1.027267e-2 |
GO:0014056 | regulation of acetylcholine secretion | 1.038625e-2 |
GO:0051261 | protein depolymerization | 1.038625e-2 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.038625e-2 |
GO:0000578 | embryonic axis specification | 1.063664e-2 |
GO:0032456 | endocytic recycling | 1.065325e-2 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 1.072138e-2 |
GO:0035404 | histone-serine phosphorylation | 1.072138e-2 |
GO:0044062 | regulation of excretion | 1.073393e-2 |
GO:0001759 | organ induction | 1.085662e-2 |
GO:0045116 | protein neddylation | 1.092333e-2 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 1.099531e-2 |
GO:0090234 | regulation of kinetochore assembly | 1.114343e-2 |
GO:0090169 | regulation of spindle assembly | 1.114343e-2 |
GO:0060166 | olfactory pit development | 1.114343e-2 |
GO:0072073 | kidney epithelium development | 1.122995e-2 |
GO:0032703 | negative regulation of interleukin-2 production | 1.132894e-2 |
GO:0042053 | regulation of dopamine metabolic process | 1.137694e-2 |
GO:0021895 | cerebral cortex neuron differentiation | 1.137773e-2 |
GO:0072166 | posterior mesonephric tubule development | 1.143109e-2 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.143109e-2 |
GO:0032727 | positive regulation of interferon-alpha production | 1.143109e-2 |
GO:0035802 | adrenal cortex formation | 1.143109e-2 |
GO:0051349 | positive regulation of lyase activity | 1.144204e-2 |
GO:0003065 | positive regulation of heart rate by epinephrine | 1.158282e-2 |
GO:0060484 | lung-associated mesenchyme development | 1.163721e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 1.165872e-2 |
GO:0001958 | endochondral ossification | 1.170093e-2 |
GO:0051257 | spindle midzone assembly involved in meiosis | 1.191511e-2 |
GO:0001975 | response to amphetamine | 1.230506e-2 |
GO:0060440 | trachea formation | 1.255437e-2 |
GO:0035810 | positive regulation of urine volume | 1.255437e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.255437e-2 |
GO:0031929 | TOR signaling cascade | 1.259030e-2 |
GO:0045604 | regulation of epidermal cell differentiation | 1.277453e-2 |
GO:0045751 | negative regulation of Toll signaling pathway | 1.282563e-2 |
GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 1.282563e-2 |
GO:2000256 | positive regulation of male germ cell proliferation | 1.282563e-2 |
GO:0044090 | positive regulation of vacuole organization | 1.282563e-2 |
GO:0015739 | sialic acid transport | 1.282563e-2 |
GO:0019428 | allantoin biosynthetic process | 1.282563e-2 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.282563e-2 |
GO:0042231 | interleukin-13 biosynthetic process | 1.282563e-2 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 1.294271e-2 |
GO:0030889 | negative regulation of B cell proliferation | 1.295446e-2 |
GO:0032481 | positive regulation of type I interferon production | 1.300649e-2 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 1.304265e-2 |
GO:0019751 | polyol metabolic process | 1.307980e-2 |
GO:0060981 | cell migration involved in coronary angiogenesis | 1.317331e-2 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 1.317331e-2 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 1.317331e-2 |
GO:0071670 | smooth muscle cell chemotaxis | 1.317331e-2 |
GO:0032602 | chemokine production | 1.317331e-2 |
GO:0000073 | spindle pole body separation | 1.317331e-2 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 1.317331e-2 |
GO:0006713 | glucocorticoid catabolic process | 1.317331e-2 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 1.317331e-2 |
GO:0051138 | positive regulation of NK T cell differentiation | 1.318918e-2 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 1.321696e-2 |
GO:0002268 | follicular dendritic cell differentiation | 1.321696e-2 |
GO:0032107 | regulation of response to nutrient levels | 1.325628e-2 |
GO:0002825 | regulation of T-helper 1 type immune response | 1.325628e-2 |
GO:0060707 | trophoblast giant cell differentiation | 1.334478e-2 |
GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway | 1.364086e-2 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 1.365234e-2 |
GO:0008366 | axon ensheathment | 1.380497e-2 |
GO:0030033 | microvillus assembly | 1.387410e-2 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 1.387410e-2 |
GO:0046323 | glucose import | 1.387410e-2 |
GO:0009826 | unidimensional cell growth | 1.387410e-2 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 1.387410e-2 |
GO:0043170 | macromolecule metabolic process | 1.415190e-2 |
GO:0032055 | negative regulation of translation in response to stress | 1.429201e-2 |
GO:0072061 | inner medullary collecting duct development | 1.430146e-2 |
GO:0072060 | outer medullary collecting duct development | 1.430146e-2 |
GO:0071603 | endothelial cell-cell adhesion | 1.430146e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.430146e-2 |
GO:0007190 | activation of adenylate cyclase activity | 1.457659e-2 |